Sunday, February 17, 2013
小龍年 200元以上生技股 誰與爭鋒 !!
Taiwan creates new niche market through medical tourism
2013/02/12 12:02:44 Taipei, Feb. 12 (CNA) Besides the traditional sightseeing tour to Taiwan that takes visitors to the Sun Moon Lake and the mountainous region of Alishan, Taiwan is also drawing tourists that are seeking to become healthier and more physically attractive.In the eastern county of Hualien, traditionally known better for its coastal scenery than medical services, 67 local medical institutions and travel operators recently joined hands to start offering high-end medical packages aimed at luring Chinese tourists.Priced at NT$500,000 (US$17,249), a seven-day package features a combination of Western-style physical checkups and clinical cosmetology, as well as Chinese preventive medicine.A 14-day package features an even higher-end health promotion and anti-aging treatment for double the price, according to a county international medical tourism association established by the local government.Buddhist Tzu Chi General Hospital in Hualien also offers interesting services in the field of medical tourism. The hospital made a name for itself by making people's legs slimmer through a calf muscle-trimming procedure, which has been drawing tourists from as far as Brazil.Since 2001, the hospital has conducted procedures on 500 pairs of legs. Twenty percent of medical tourists coming to the Hualien hospital were from China, Hong Kong, Macau, the United States, Canada and Japan.What is happening in Hualien is part of a larger picture in Taiwan, where policymakers are attaching more importance to medical tourism as a new niche market and a way to boost the country's economy.According to the Taiwan External Trade Development Council (TAITRA), Taiwan's top trade promoter, Taiwan recorded the arrival of 81,462 medical tourists as of the end of the third quarter of 2012, more than double the 39,428 visitors flocking to the country in 2011.Among those treated in 2012, 60 percent came to Taiwan to get treatment for their illnesses, 27 percent for health check-ups, while 13 percent came for cosmetic surgery, according to the TAITRA.Last December, Minister without Portfolio Kuang Chung-ming proposed setting up a "service industry experimental zone" near the Taiwan Taoyuan International Airport, the country's main international gateway that would offer "derivative services from tourism."The "derivative services" include sectors spanning travel, shopping, clinical cosmetology and financial services, which will cater to the needs of international visitors.Kuang said the idea of the zone was part of the efforts aimed at boosting Taiwan's employment by cultivating the service industry, with especially high-paying service jobs.The Cabinet-level Council for Economic Planning and Development also floated the idea of "free economic demonstration zones" that will foster the development of Taiwan into regional hubs for providing critical medical care and medical tourism, industrial innovation, international logistics, global talent training and agricultural product sales.Meanwhile, Taiwan, in particular has been striving to attract tourists from China, given the two countries' linguistic and cultural similarities.According to the TAITRA, three million people a year in China were opting for plastic surgery. The cosmetic surgery market in China had grown by 10 percent annually, which is the highest in Asia and had surpassed the global average of 6 percent, the pointed out.Taiwan also launched a 15-day medical tourism visa in January last year to cater to Chinese tourists. In August 2012, it also promoted an e-visa service that will help make things easier for Chinese tourists visiting Taiwan for physical checkups, cosmetic surgery or anti-aging treatments.
金卫医疗 甘源 (Kam Yuen) 奋斗
甘源:善于发现商机的中国企业家 2013-01-06 11:06来源:FT中文网 作者:桑晓霓 甘源(Kam Yuen)占据着香港最大的首席执行官办公室之一,位于贝聿铭(IM Pei)设计的中国银行(BoC)大楼的46层,山水景色尽收眼底。真皮沙发和按摩椅摆着一辆健身脚踏车。桌子和窗台上摆着金像。摆金像是为了带来好运。甘源一直深信运气,尤其相信自己的运气。他可能真的鸿运高照。他创立了两家企业:金卫医疗集团有限公司(Golden Meditech Holdings)和中国脐带血库企业集团(China Cord Blood Corp),如今两家企业都已上市。曾在美国收购集团德州太平洋集团(TPG)呼风唤雨的单伟建持有前者的股份,而私人股本集团KKR则持有后者的股份。分析人士估计,仅仅根据甘源在金卫医疗所持股份,他的身家就可能达到1亿美元。甘源是新中国的面孔,体现着它的力量和局限。就像很多企业家一样,他发家致富是通过发现套利机会,而不是在产品创新或科技方面取得突破。尽管甘源基本上是靠个人奋斗(而不是靠关系)取得成功的,但如今"太子"们开始拉拢他,而他与权势人物的关系帮助他的企业兴旺发达。甘源晃动着一根雪茄说:"我从没想过我不能成功。"现年51岁的甘源看起来比实际年龄年轻得多。他在北京长大,父母希望他成为一名医生,但他违背父母的愿望,去了北京第二外国语学院学习。他没学成英语,倒是把日语学得不错。毕业后,他加入了一家国有金属贸易公司——五矿集团(Minmetals),上世纪80年代末被派往日本。当时东京大概是全世界最昂贵的城市。作为一家中国国有企业中资历尚浅的员工,这名年轻的工作人员只拿到微薄的津贴。他回忆道:"我每个月拿70元人民币。我想要更加独立。"于是甘源寻觅更加赚钱的方式来养活自己。他很快发现,日本的医院总在丢弃医疗设备,用最新一代的医疗设备来替代运行正常的机器,为了扔掉较旧的型号还要向垃圾处理公司支付一大笔钱。从汽车到沙发,日本人喜欢丢掉在其他地方被认为质量还相当好的产品,这种习惯是出了名的。但甘源从中发现了商机。他拜访了数十家日本医院,说服他们把用过的X光、超声波和其他机器免费送给他。然后甘源把这些机器卖给中国的医院。当时,中国医院的成像设备只能拍黑白片。具有更高级成像技术的进口设备被抢购一空。甘源回忆道:"中国的机器拍不出颜色。这让日本人感觉良好。我让日本人觉得,他们是在帮助中国。很快我就成了百万富翁。"不过,这种高尚行为的光环最后消失。甘源说,他被告知,原先可以免费获得的设备得开始花钱买了。这对他是一个问题,因为把设备卖给中国医院时他收到的是人民币,但他需要付日元给日本人。所以他必须在日本卖些东西换取日元。甘源是名虔诚的佛教徒,他在一个出人意料的地方发现了机会。日本寺庙不必纳税,还能从举办殡葬大赚一把。这名年轻的企业家决定向寺庙供应从中国进口的大理石墓碑,"以此解决我的外汇问题"。金卫医疗称自己是中国领先的综合性医疗事业集团,这一领域"需要政府支持,符合政府政策"。这位创始人指出:"我不和国有机构竞争。我的客户都是高端客户。"这家公司拥有首家外资独资的中国全国性医院管理业务,还拥有一个医疗设备部门。截止2012年3月结束的财年,该公司税后利润下跌48%,至8400万港元。甘源把下跌的原因归因于金融市场动荡。鉴于他对企业的信心以及现行股价未能反应金卫医疗内在价值的感觉,今年6月份他告诉股东,他把自己所持股份增至22.2%。就像中国的很多企业一样,金卫医疗是一个人的表演。甘源身兼主席、首席执行官以及首席合规官,这让公司治理纯粹主义者不安。但在他看来,这完全合理。(译者/倪卫国)
Fitness trackers are long on hype, short on credibility
By Daniela Hernandez23 January 13 We are awash in personal data trackers. There are wristbands, headbands, watches, smart scales, helmets and even forks to help us track our weight, heart rate, blood pressure and glucose level while logging how far we walk and how many calories we burn. All this information is supposed to give us behaviour-morphing insights into our personal health habits.Trouble is, no one can say for sure that any of it makes us healthier. Oh sure, these gadgets might get us psyched up to exercise, and they might encourage us to take the stairs instead of the elevator, but there has not yet been any scientific exploration of whether fitness gadgets, like the Fitbit Flex or Withings Smart Activity Monitor, actually work like they should."The durability of the effect is still in question," said Dr Eric Topol, the director of the Scripps Translational Science Institute. "We don't have randomised [clinical] trials showing improved outcomes or durability in influencing behaviour."You wouldn't know that walking through the South Hall of the Las Vegas Convention Centre during CES, where more than 220 companies showed off their digital health gadgets. They all used pictures of youthful, happy, svelte people lacing up running shoes, eating salads and playing outdoors. Their booths were filled with attractive, fit gals and guys.The message is clear: These devices will help improve your health and physique.But so far there aren't many studies or trials testing the effectiveness of activity trackers or health monitors at getting us to move more and eat better foods or whether digital sensors are any better than old-school approaches like Weight Watchers.Many of these devices have been developed by startups or Kickstarter campaigns and simply don't have the deep pockets necessary to finance expensive clinical trials, says Topol.Some researchers, Topol included, are following the wave of health technology with studies testing how activity monitors and other digital health sensors influence outcomes for chronic illnesses like cardiac disease and diabetes.Other scientists at the University of California, San Francisco; Mayo Clinic; Massachusetts General Hospital; and Aurora Health Care are conducting trials to determine how digital data trackers affect activity levels, obesity and dietary intake in various populations. Some of these trials are just now recruiting patients or recently finished collecting data.Dr Anne Thorndike, a researcher at Harvard Medical School, is wrapping up a study of Fitbit's effect on activity levels among medical residents. She couldn't share all her findings because she's still submitting her study for publication, but said there was some fatigue over the course of her 12-week study, suggesting the motivating effect of information, badges and notifications might be short-lived. That's to be expected. As with any new toy or gadget, the novelty wears off.A 2007 study in the Journal of the American Medical Association found that using pedometers, activity monitors and step counters was associated with being more physically active and having a lower body mass index and blood pressure. But the authors note, "whether these changes are durable over the long term is undetermined."The key to prolonging people's engagement with their trackers might be to harness the social networking features built into the devices. Some research has shown social networks can impact health outcomes for patients with migraine, obesity and ALS, but whether that will translate to sensor-based social networks remains to be seen.At this point, the connection between sensor-collected data and a patient's official (electronic) health record also is not well defined. There's no simple interface to upload data collected by biometric sensors into medical health records short of printing out your data, scanning it and converting it into a PDF you can send to your doctor.That might become more of an issue as personal data trackers mature from pedometers pimped out with great user interfaces into hardware that's being added to mobile devices to gather data typically collected by physicians, like electrocardiograms, galvanic skin response and blood oxygenation and glucose levels, says Topol. And that democratisation of health care is what he sees as the biggest benefit of these devices. He predicts 2013 will see more "medical wearables," which will make studying conditions like sleep apnea more comfortable and less expensive for patients.The next step is the commercialisation of sensors floating around in our bloodstreams or implanted in our skin, teeth or brains.As these medical sensors become more pervasive, companies also will have to be conscious of how they market their products. For example, the Masimo iSpO2 pulse oximeter is approved for consumers to measure their own blood oxygen levels and pulse rates using the similar technology used in hospitals. But because it's not approved for medical use, doctors can't use it or have their patients use products like this until they are approved by the Food and Drug Administration. AliveCor, which makes a portable electrocardiogram built into an iPhone case, faced similar issues until it was approved by the FDA in December."It's like the wild, wild West," said Dr Atul Butte of the Stanford School of Medicine, who just started using a Fitbit and an Aria Scale. "For a drug company, there's such a burden to show how [their product] works better. A gadget maker is … not required to show that data and that's kind of unfair.""Probably, like most gadgets, these devices help those folks on the borderline, [those] ready to make behavioural changes and looking for something to tip them into healthy behaviours," he added.
Doctors see Apple's iPhone as life saver in 'the future of medicine'
By Kevin Bostic Friday, January 25, 2013, 02:37 pmWhile some iPhone users see their smartphones as a figurative life saver, Dr. Eric Topol put Apple's popular smartphone to such use literally on a recent flight from Washington, D.C., to San Diego. As Rock Center with Brian Williams details, Topol used his iPhone, in combination with an AliveCor — an iPhone-mounted sensor capable of delivering clinically accurate electrocardiograms — to measure the vital signs of a passenger experiencing severe chest pains at 30,000 feet.When the readings indicated that the passenger was, in fact, having a heart attack, Topol recommended an urgent landing. The passenger survived after being rushed to the hospital.According to Topol, the proliferation of apps that allow patients to measure and monitor their vital signs represents a revolution in the medical world. Devices like the iPhone, he says, will soon be able to pair with ingested or injected sensors: monitoring blood flow, sugar levels, sleep habits, heart rates, and more.When one of these sensors picks up data of note, it will be able to contact a patient's smartphone, or even a patient's doctor in order to alert the physician and schedule an appointment. Such technology could cut down on inefficient practices such as mass screenings for things like breast cancer, with patients instead monitoring their own hormone and blood chemistry levels with smartphone-paired sensors.The medical community is moving toward and adopting technologies such as these in fits and starts, encouraged by the utility and portability of devices such as the iPad mini, but occasionally stymied by regulatory concerns. Physicians have by some accounts, been quicker to adopt the iPad for use in their practices than they have the electronic health record systems mandated by the Affordable Care Act.The other end of the medical future that Topol envisions, though, will be slower to come. While advancements have been made in wireless technologies and sensors, the medical community has been slower to adopt those devices than it has tablets and smartphones.The pace of improvement in those devices continues to accelerate, though, and it may not be too far in the future when smartphone users won't have to call their doctor for an appointment, because their smartphone will have already done so for them.
